The efficacy 3 months of dual antiplatelet therapy is similar to 12 months in patients with acute coronary syndrome
1. 3 months of dual antiplatelet therapy (DAPT) in patients treated with Firehawk stents was non-inferior to 12 months of ...
Tag: DAPT
#VisualAbstract: Switching from ticagrelor to clopidogrel may demonstrate benefit in patients with large body mass index and prior myocardial infarction
1. A deescalation strategy involving switching from ticagrelor to clopidogrel in patients with acute myocardial infarction (AMI) was associated with ...
Switching from ticagrelor to clopidogrel may demonstrate benefit in patients with large body mass index and prior myocardial infarction
1. A deescalation strategy involving switching from ticagrelor to clopidogrel in patients with acute myocardial infarction (AMI) was associated with ...
Ticagrelor monotherapy reduces bleeding risk compared to dual antiplatelet therapy for patients following coronary stenting
1. Ticagrelor was non-inferior to DAPT for the incidence of major adverse cardiovascular and cerebrovascular events. 2. Ticagrelor monotherapy significantly ...
Ticagrelor and aspiring dual antiplatelet therapy is favourable over monotherapy following coronary artery bypass
1. Dual antiplatelet therapy with ticagrelor and asprin led to a significantly lower risk of major adverse cardiovascular events over ...
Ticagrelor with aspirin may be superior to clopidogrel and aspirin for preventing stroke in certain patients
1. In this post-hoc analysis of the CHANCE-2 trial, ticagrelor-acetylsalicylic acid was more beneficial compared to clopidogrel-acetylsalicylic acid for preventing ...
Ticagrelor-acetylsalicylic acid may reduce stroke risk further for obese patients than clopidogrel
1. For obese patients with minor stroke or transient ischemic attacks (TIA), subsequent therapy with ticagrelor-acetylsalicylic acid (ASA) was associated ...
Dual antiplatelet therapy discontinued 9 months after percutaneous coronary intervention associated with improved morbidity and mortality
1. For patients with second-generation drug-eluting stents, discontinuation of dual antiplatelet therapy (DAPT) 9 months post-percutaneous coronary intervention (PCI) was ...
#VisualAbstract: Effect of ticagrelor monotherapy vs ticagrelor with aspirin on major bleeding and cardiovascular events (TICO trial)
1. Patients status-post placement of drug-eluting stents (DES) for acute coronary syndrome received three months of Ticagrelor and Aspirin dual-antiplatelet ...
